{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "a7434fa0",
   "metadata": {},
   "source": [
    "# Data Processor\n",
    "\n",
    "#### Given a csv file with relations of the form 'head', 'type', and 'tail' format, this file implements methods to get sub dataframes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "426bb0f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "import networkx as nx\n",
    "import pandas as pd\n",
    "from collections import Counter\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "568afcdf",
   "metadata": {},
   "outputs": [],
   "source": [
    "#"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "764df2a8",
   "metadata": {},
   "outputs": [],
   "source": [
    "class DataProcessor():\n",
    "    \n",
    "    # Contructing the object\n",
    "    def __init__(self, file_path):\n",
    "        self.df = pd.read_csv(file_path)\n",
    "        word_counter = Counter()\n",
    "        relations_counter = Counter()\n",
    "        \n",
    "        for index, row in self.df.iterrows():\n",
    "            word_counter.update([row['head'], row['tail']])\n",
    "            relations_counter.update([row['type']])\n",
    "        self.word_counter = word_counter\n",
    "        self.relations_counter = relations_counter\n",
    "    \n",
    "    # This method accepts relations as input and\n",
    "    # outputs the sub-dataframe with the wanted relations.\n",
    "    def get_df_with_relation(self, *relations):\n",
    "        mp = {0:'head', 1:'type', 2:'tail'}\n",
    "        columns = ['head', 'type','tail']\n",
    "        new_df = pd.DataFrame(columns=columns) \n",
    "        for index, row in self.df.iterrows():\n",
    "            if row['type'] in relations:\n",
    "                new_df.loc[len(new_df)] = [row[mp[i]] for i in range(3)]\n",
    "        return new_df       \n",
    "    \n",
    "    # This method accepts words as input and\n",
    "    # outputs the sub-dataframe with the wanted words.\n",
    "    def get_df_with_word(self, *words):        \n",
    "        mp = {0:'head', 1:'type', 2:'tail'}\n",
    "        columns = ['head', 'type','tail']\n",
    "        new_df = pd.DataFrame(columns=columns) \n",
    "        for index, row in self.df.iterrows():\n",
    "            if row['head'] in words or row['tail'] in words:\n",
    "                new_df.loc[len(new_df)] = [row[mp[i]] for i in range(3)]\n",
    "        return new_df\n",
    "    \n",
    "    # This method accepts words and relations as input and\n",
    "    # outputs the sub-dataframe with the wanted words and relations.\n",
    "    def get_df_with_word_relation(self, words=[], relations=[]):\n",
    "        mp = {0:'head', 1:'type', 2:'tail'}\n",
    "        columns = ['head', 'type','tail']\n",
    "        new_df = pd.DataFrame(columns=columns) \n",
    "        for index, row in self.df.iterrows():\n",
    "            if (row['head'] in words or row['tail'] in words) and row['type'] in relations:\n",
    "                new_df.loc[len(new_df)] = [row[mp[i]] for i in range(3)]\n",
    "        return new_df\n",
    "\n",
    "    \n",
    "        \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "d0c890f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "file_path = 'data/filtered_triplets.csv'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "8bf44616",
   "metadata": {},
   "outputs": [],
   "source": [
    "generator = DataProcessor(file_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "72ff61e5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('SARS CoV 2', 89),\n",
       " ('COVID 19', 60),\n",
       " ('RNA', 51),\n",
       " ('DNA', 50),\n",
       " ('China', 47),\n",
       " ('Brazil', 44),\n",
       " ('mRNA', 39),\n",
       " ('taxa', 29),\n",
       " ('United States', 28),\n",
       " ('T cell', 26),\n",
       " ('miRNA', 24),\n",
       " (\"Alzheimer's disease\", 24),\n",
       " ('in vitro', 23),\n",
       " ('in vivo', 22),\n",
       " ('domains', 22),\n",
       " ('IL 6', 21),\n",
       " ('MRI', 21),\n",
       " ('TNF α', 20),\n",
       " ('HIV', 19),\n",
       " ('EGFR', 19),\n",
       " ('GWAS', 19),\n",
       " ('PubMed', 18),\n",
       " ('CRISPR', 18),\n",
       " ('HBV', 18),\n",
       " ('COVID 19 pandemic', 17),\n",
       " ('miRNAs', 17),\n",
       " ('Omicron', 17),\n",
       " ('C', 17),\n",
       " ('USA', 17),\n",
       " ('NF κB', 16),\n",
       " ('AMPK', 16),\n",
       " ('Canada', 14),\n",
       " ('non small cell lung cancer', 14),\n",
       " ('Protein', 14),\n",
       " ('Cas9', 13),\n",
       " ('severe acute respiratory syndrome coronavirus 2', 13),\n",
       " ('control group', 13),\n",
       " ('CKD', 13),\n",
       " ('IL 1β', 13),\n",
       " ('OSCC', 13),\n",
       " ('B', 13),\n",
       " ('GBM', 13),\n",
       " ('Mn', 12),\n",
       " ('Europe', 12),\n",
       " ('OS', 12),\n",
       " ('NIH', 12),\n",
       " ('NSCLC', 12),\n",
       " ('Illumina', 11),\n",
       " ('Japan', 11),\n",
       " ('Russia', 11),\n",
       " ('T2DM', 11),\n",
       " ('R', 11),\n",
       " ('Sanger sequencing', 11),\n",
       " ('Spain', 11),\n",
       " ('India', 11),\n",
       " ('PDAC', 11),\n",
       " ('SLE', 11),\n",
       " ('type 2 diabetes', 11),\n",
       " ('AML', 11),\n",
       " ('Escherichia coli', 10),\n",
       " ('Delta', 10),\n",
       " ('CD8', 10),\n",
       " ('model organism', 10),\n",
       " ('noncoding RNA', 10),\n",
       " ('lncRNA', 10),\n",
       " ('HCC', 10),\n",
       " ('KEGG', 10),\n",
       " ('BRCA1', 10),\n",
       " ('Macaronesia', 10),\n",
       " ('GC', 10),\n",
       " ('MM', 10),\n",
       " ('PCOS', 10),\n",
       " ('STAT3', 10),\n",
       " ('pro inflammatory cytokines', 10),\n",
       " ('LPS', 10),\n",
       " ('N', 10),\n",
       " ('IAV', 10),\n",
       " ('Serratia', 10),\n",
       " ('Big Five', 10),\n",
       " ('OvCa', 10),\n",
       " ('Web of Science', 9),\n",
       " ('microRNA', 9),\n",
       " ('T2D', 9),\n",
       " ('NK cell', 9),\n",
       " ('ADCC', 9),\n",
       " ('chemical compound', 9),\n",
       " ('RNA seq', 9),\n",
       " ('DNA methylation', 9),\n",
       " ('PD 1', 9),\n",
       " ('MS', 9),\n",
       " ('Salmonella', 9),\n",
       " ('B cell', 9),\n",
       " ('expression levels', 9),\n",
       " ('red blood cell', 9),\n",
       " ('A', 9),\n",
       " ('β tubulin', 9),\n",
       " ('virome', 9),\n",
       " ('enrichment analysis', 9),\n",
       " ('expensive', 9),\n",
       " ('Saccharomyces cerevisiae', 9),\n",
       " ('Kenya', 9),\n",
       " ('MOF', 9),\n",
       " ('PJW/PP1 complex', 9),\n",
       " ('anterior', 9),\n",
       " ('vitamin B', 9),\n",
       " ('CRC', 9),\n",
       " ('immune response regulation network', 9),\n",
       " ('β catenin', 8),\n",
       " ('post translational modification', 8),\n",
       " ('non coding RNA', 8),\n",
       " ('NAFLD', 8),\n",
       " ('Coronavirus disease 2019', 8),\n",
       " ('ELISA', 8),\n",
       " ('PD L1', 8),\n",
       " ('mesenchymal stem cell', 8),\n",
       " ('pH', 8),\n",
       " ('University of Ulm', 8),\n",
       " ('PARP2', 8),\n",
       " ('Fe', 8),\n",
       " ('IGF 1', 8),\n",
       " ('ML', 8),\n",
       " ('recurrent gene', 8),\n",
       " ('LRR', 8),\n",
       " ('PD', 8),\n",
       " ('EC', 8),\n",
       " ('Swedish state', 8),\n",
       " ('T cell receptor', 8),\n",
       " ('OAS family', 8),\n",
       " ('atorvastatin', 8),\n",
       " ('South America', 8),\n",
       " ('CoQ10', 8),\n",
       " ('EMT', 8),\n",
       " ('AlereLAM', 8),\n",
       " ('Xpert', 8),\n",
       " ('markers of mitochondrial biogenesis', 8),\n",
       " ('circRNAs', 8),\n",
       " ('NPs', 8),\n",
       " ('HR QoL', 8),\n",
       " ('EVs', 8),\n",
       " ('Mol*VS', 8),\n",
       " ('HmsD', 8),\n",
       " ('Vascular endothelial growth factor', 8),\n",
       " ('BV', 8),\n",
       " ('BPM', 8),\n",
       " ('Interprofessional Education Collaborative', 8),\n",
       " ('PEER', 8),\n",
       " ('HFD', 7),\n",
       " ('TME', 7),\n",
       " ('hazard ratio', 7),\n",
       " ('X ray', 7),\n",
       " ('microRNAs', 7),\n",
       " ('PFS', 7),\n",
       " ('MDA', 7),\n",
       " ('2009', 7),\n",
       " ('RNA sequencing', 7),\n",
       " ('PARP1', 7),\n",
       " ('Drosophila', 7),\n",
       " ('CD4', 7),\n",
       " ('RAD51', 7),\n",
       " ('AI', 7),\n",
       " ('IBD', 7),\n",
       " ('Caribbean', 7),\n",
       " ('nucleic acid detection', 7),\n",
       " ('gestation', 7),\n",
       " ('Gansu', 7),\n",
       " ('United Kingdom', 7),\n",
       " ('knockdown', 7),\n",
       " ('Asia', 7),\n",
       " ('Kyoto Encyclopedia of Genes and Genomes', 7),\n",
       " ('nomogram', 7),\n",
       " ('Iran', 7),\n",
       " ('PANNM', 7),\n",
       " ('Sweden', 7),\n",
       " ('VII', 7),\n",
       " ('Gene Expression Omnibus', 7),\n",
       " ('time consuming', 7),\n",
       " ('messenger RNA', 7),\n",
       " ('Enterobacterales', 7),\n",
       " ('Africa', 7),\n",
       " ('ESBL', 7),\n",
       " ('2D culture', 7),\n",
       " ('CENPO', 7),\n",
       " ('TRPV1', 7),\n",
       " ('Cnidaria', 7),\n",
       " ('pro inflammatory factors', 7),\n",
       " ('G protein coupled receptor', 7),\n",
       " ('complex I', 7),\n",
       " ('CHD', 7),\n",
       " ('AS', 7),\n",
       " ('5 ARI', 7),\n",
       " ('emergency department', 7),\n",
       " ('Germany', 7),\n",
       " ('evolutionary families', 7),\n",
       " ('similarity measure', 7),\n",
       " ('rubidaea', 7),\n",
       " ('STN', 7),\n",
       " ('EID CT', 7),\n",
       " ('ST', 7),\n",
       " ('HMGB1', 7),\n",
       " ('DERBGs', 7),\n",
       " ('dura mater', 7),\n",
       " ('food allergies', 7),\n",
       " ('posterior deltoid bellies', 7),\n",
       " ('TCA cycle', 7),\n",
       " ('cell signaling molecules', 7),\n",
       " ('DCM', 6),\n",
       " ('ATP', 6),\n",
       " ('MEDLINE', 6),\n",
       " ('low risk', 6),\n",
       " ('OM', 6),\n",
       " ('mRNAs', 6),\n",
       " ('Scopus', 6),\n",
       " ('controls', 6),\n",
       " ('White', 6),\n",
       " ('Black', 6),\n",
       " ('bioactive substances', 6),\n",
       " ('Shanghai', 6),\n",
       " ('P', 6),\n",
       " ('Python', 6),\n",
       " ('TBI', 6),\n",
       " ('natural environment', 6),\n",
       " ('1', 6),\n",
       " ('vascular endothelial growth factor', 6),\n",
       " ('regulatory mechanisms', 6),\n",
       " ('SNPs', 6),\n",
       " ('intestinal livestock schistosomiasis', 6),\n",
       " ('MAPK', 6),\n",
       " ('HIV uninfected', 6),\n",
       " ('PCR', 6),\n",
       " ('Beijing', 6),\n",
       " ('T lymphocyte', 6),\n",
       " ('side effect', 6),\n",
       " ('Uganda', 6),\n",
       " ('Croatia', 6),\n",
       " ('Slovenia', 6),\n",
       " ('3', 6),\n",
       " ('Bayesian mechanics', 6),\n",
       " ('Ulcer Inhibition', 6),\n",
       " ('ubiquitin ligase', 6),\n",
       " ('mRNA vaccine', 6),\n",
       " ('SA', 6),\n",
       " ('HR', 6),\n",
       " ('Zn', 6),\n",
       " ('As', 6),\n",
       " ('TGF β', 6),\n",
       " ('University of Pennsylvania', 6),\n",
       " ('inducible system', 6),\n",
       " ('AA', 6),\n",
       " ('BNT162b2', 6),\n",
       " ('AD', 6),\n",
       " ('whole exome sequencing', 6),\n",
       " ('traditional Chinese medicine', 6),\n",
       " ('structural domain', 6),\n",
       " ('Klebsiella pneumoniae', 6),\n",
       " ('sugar fed', 6),\n",
       " ('blood fed', 6),\n",
       " ('ER', 6),\n",
       " ('T cells', 6),\n",
       " ('efflux pump', 6),\n",
       " ('Mediterranean Sea', 6),\n",
       " ('UIA instability', 6),\n",
       " ('Peking University', 6),\n",
       " ('WT', 6),\n",
       " ('ICSI', 6),\n",
       " ('IVF', 6),\n",
       " ('ZIKV', 6),\n",
       " ('N terminus', 6),\n",
       " ('Mato Grosso do Sul', 6),\n",
       " ('Chronic kidney disease', 6),\n",
       " ('IgG', 6),\n",
       " ('CS', 6),\n",
       " ('North America', 6),\n",
       " ('NLRP3', 6),\n",
       " ('Cancer', 6),\n",
       " ('IgG1', 6),\n",
       " ('NASH', 6),\n",
       " ('PSII', 6),\n",
       " ('medium', 6),\n",
       " ('BEV', 6),\n",
       " ('SARS CoV 2 infection', 6),\n",
       " ('Proteobacteria', 6),\n",
       " ('trachea', 6),\n",
       " ('protein interaction database', 6),\n",
       " ('Autophagy', 6),\n",
       " ('IR', 6),\n",
       " ('Drp1', 6),\n",
       " ('IL 10', 6),\n",
       " ('purine metabolic pathways', 6),\n",
       " ('vesicular stomatitis virus', 6),\n",
       " ('PEP', 6),\n",
       " ('PWH', 6),\n",
       " ('high risk', 6),\n",
       " ('somatic mutation', 6),\n",
       " ('serotonin receptor', 6),\n",
       " ('water/hexadecane interface', 6),\n",
       " ('Seoul', 6),\n",
       " ('α blocker', 6),\n",
       " ('2D', 6),\n",
       " ('Vegf', 6),\n",
       " ('Principal component analysis', 6),\n",
       " ('SCI', 6),\n",
       " ('SND', 6),\n",
       " ('ERS related risk model', 6),\n",
       " ('TISIDB', 6),\n",
       " ('BOM', 6),\n",
       " ('metagenome', 6),\n",
       " ('PGF2α analogues', 6),\n",
       " ('26S proteasome', 6),\n",
       " ('apoptotic pathways', 6),\n",
       " ('kernel row number', 6),\n",
       " ('DUX4', 6),\n",
       " ('urinary tract infection', 6),\n",
       " ('SERS', 6),\n",
       " ('valosin containing protein', 6),\n",
       " ('RT nestRPA', 6),\n",
       " ('middle deltoid bellies', 6),\n",
       " ('Balkan Peninsula', 6),\n",
       " ('hiPSC CMs', 6),\n",
       " ('translation machinery', 6),\n",
       " ('betaine', 6),\n",
       " ('epididymis', 6),\n",
       " ('Axl', 6),\n",
       " ('β sitosterol', 6),\n",
       " ('EF', 6),\n",
       " ('graft versus host', 6),\n",
       " ('MRD', 6),\n",
       " ('domain', 5),\n",
       " ('CIPK23', 5),\n",
       " ('NRAMP1', 5),\n",
       " ('CM', 5),\n",
       " ('modules', 5),\n",
       " ('BC', 5),\n",
       " ('Ca', 5),\n",
       " ('COVID 19 vaccine', 5),\n",
       " ('Italy', 5),\n",
       " ('2008', 5),\n",
       " ('English language', 5),\n",
       " ('CD', 5),\n",
       " ('disease recurrence', 5),\n",
       " ('small intestine', 5),\n",
       " ('grooming', 5),\n",
       " ('dendritic cell', 5),\n",
       " ('univariate', 5),\n",
       " ('MYC', 5),\n",
       " ('Dayri', 5),\n",
       " ('date palm', 5),\n",
       " ('Estemaran', 5),\n",
       " ('Zahedi', 5),\n",
       " ('siRNA', 5),\n",
       " ('NMR', 5),\n",
       " ('World Health Organization', 5),\n",
       " ('FIB milling', 5),\n",
       " ('Netherlands', 5),\n",
       " ('omics', 5),\n",
       " ('regression model', 5),\n",
       " ('ERK', 5),\n",
       " ('PcG', 5),\n",
       " ('nerve ring', 5),\n",
       " ('TRPV3', 5),\n",
       " ('UK', 5),\n",
       " ('Ivory billed Woodpecker', 5),\n",
       " ('Israel', 5),\n",
       " ('Singapore', 5),\n",
       " ('restriction enzyme', 5),\n",
       " ('murine', 5),\n",
       " ('ST678', 5),\n",
       " ('AA families', 5),\n",
       " ('reporter', 5),\n",
       " ('end bulb', 5),\n",
       " ('South Korea', 5),\n",
       " ('asymptomatic', 5),\n",
       " ('DLB', 5),\n",
       " ('AM6545', 5),\n",
       " ('AM4113', 5),\n",
       " ('amyloid β', 5),\n",
       " ('TRIM21', 5),\n",
       " ('Candida albicans', 5),\n",
       " ('Macrophage', 5),\n",
       " ('Icon FES', 5),\n",
       " ('Depression', 5),\n",
       " ('PAs', 5),\n",
       " ('TLR2', 5),\n",
       " ('Morocco', 5),\n",
       " ('In vitro', 5),\n",
       " ('GFP', 5),\n",
       " ('MI', 5),\n",
       " ('immune checkpoint blockade', 5),\n",
       " ('SCLC', 5),\n",
       " ('RT qPCR', 5),\n",
       " ('NRF2', 5),\n",
       " ('statistical significance', 5),\n",
       " ('welfare', 5),\n",
       " ('primary tumor resection', 5),\n",
       " ('VPS13A', 5),\n",
       " ('Zika virus', 5),\n",
       " ('loci', 5),\n",
       " ('Plasmodium EB1', 5),\n",
       " ('morphological identification', 5),\n",
       " ('moiety', 5),\n",
       " ('MCPyV', 5),\n",
       " ('E cadherin', 5),\n",
       " ('APSK2', 5),\n",
       " ('rac dinotefuran', 5),\n",
       " ('monolayer', 5),\n",
       " ('Giardia', 5),\n",
       " ('TIM 3', 5),\n",
       " ('Antarctica', 5),\n",
       " ('steatosis', 5),\n",
       " ('PE', 5),\n",
       " ('SSM', 5),\n",
       " ('PROSPERO', 5),\n",
       " ('anti fouling compound', 5),\n",
       " ('0.2 0.6', 5),\n",
       " ('PTSD', 5),\n",
       " ('N terminal domain', 5),\n",
       " ('STING', 5),\n",
       " ('bulbar onset ALS', 5),\n",
       " ('ELOVL4', 5),\n",
       " ('cccDNA', 5),\n",
       " ('health related quality of life', 5),\n",
       " ('immune checkpoint inhibitor', 5),\n",
       " ('DDX41VUS', 5),\n",
       " ('DDX41path', 5),\n",
       " ('HCV', 5),\n",
       " ('combination therapy', 5),\n",
       " ('CD9', 5),\n",
       " ('Western blot', 5),\n",
       " ('chromosome 3', 5),\n",
       " ('STAT1', 5),\n",
       " (\"People's Republic of China\", 5),\n",
       " ('oxidative stress markers', 5),\n",
       " ('CAL', 5),\n",
       " ('England', 5),\n",
       " ('Iraq', 5),\n",
       " ('US', 5),\n",
       " ('4T1@DOX/CS NPs', 5),\n",
       " ('K.L.and K.T.', 5),\n",
       " ('signal amplification', 5),\n",
       " ('precursor', 5),\n",
       " ('ECM', 5),\n",
       " ('low ', 5),\n",
       " ('WR', 5),\n",
       " ('IL 1α', 5),\n",
       " ('VEGFR1', 5),\n",
       " ('VEGFR2', 5),\n",
       " ('lymph node', 5),\n",
       " ('L SND', 5),\n",
       " ('biomolecule based microarray', 5),\n",
       " ('Charolais', 5),\n",
       " ('Limousin', 5),\n",
       " ('MAVS', 5),\n",
       " ('AD treatment', 5),\n",
       " ('quantitative trait loci', 5),\n",
       " ('Ex + PR + ACr', 5),\n",
       " ('invadopodia', 5),\n",
       " ('AIS', 5),\n",
       " ('IgG2a', 5),\n",
       " ('serological test', 5),\n",
       " ('T6SS', 5),\n",
       " ('TDP C', 5),\n",
       " ('4 years', 5),\n",
       " ('95% CI', 5),\n",
       " ('ACD', 5),\n",
       " ('T cell markers', 5),\n",
       " ('C57BL/6', 5),\n",
       " ('MAG', 5),\n",
       " ('ICA stenosis', 5),\n",
       " ('H3K9 methyltransferase', 5),\n",
       " ('JZ', 5),\n",
       " ('J', 5),\n",
       " ('TC', 5),\n",
       " ('CGM', 5),\n",
       " ('Kriab mirror', 5),\n",
       " ('congenital heart defects', 5),\n",
       " ('Phafin2', 5),\n",
       " ('BP', 5),\n",
       " ('STAU2', 5),\n",
       " ('niches', 5),\n",
       " ('22q11DS', 5),\n",
       " ('7/8MMUD', 5),\n",
       " ('MIS C', 5),\n",
       " ('chow', 4),\n",
       " ('shoot', 4),\n",
       " ('Mn transporter', 4),\n",
       " ('Plant', 4),\n",
       " ('secondary metabolism', 4),\n",
       " ('Arabidopsis', 4),\n",
       " ('overexpressing', 4),\n",
       " ('in silico', 4),\n",
       " ('Stem cell', 4),\n",
       " ('2004', 4),\n",
       " ('retenedores fijos', 4),\n",
       " ('tratamiento', 4),\n",
       " ('DNA damage', 4),\n",
       " ('dimer', 4),\n",
       " ('PTMs', 4),\n",
       " ('QTL', 4),\n",
       " ('Day 28', 4),\n",
       " (\"3',5' cAMP\", 4),\n",
       " ('tandem mass spectrometry', 4),\n",
       " ('mechanism of action', 4),\n",
       " ('CXCL10', 4),\n",
       " ('Breast cancer', 4),\n",
       " ('MicroRNA', 4),\n",
       " ('rhabdomyolysis', 4),\n",
       " ('Agaricomycete', 4),\n",
       " ('third dose', 4),\n",
       " ('anticancer agent', 4),\n",
       " ('ADRD', 4),\n",
       " ('annexins', 4),\n",
       " ('2', 4),\n",
       " ('United Nations', 4),\n",
       " ('General Assembly', 4),\n",
       " ('LRRK2', 4),\n",
       " (\"Parkinson's disease\", 4),\n",
       " ('University of California, Berkeley', 4),\n",
       " ('Berkeley, California', 4),\n",
       " ('Cu', 4),\n",
       " ('Hispanic White', 4),\n",
       " ('SCD', 4),\n",
       " ('meniscal body', 4),\n",
       " ('Pakistan', 4),\n",
       " ('scientific database', 4),\n",
       " ('Google Scholar', 4),\n",
       " ('ESCRT', 4),\n",
       " ('Gag lattice', 4),\n",
       " ('molecular model', 4),\n",
       " ('Indonesia', 4),\n",
       " ('Female', 4),\n",
       " ('therapeutic strategies', 4),\n",
       " ('Sclerotinia sclerotiorum', 4),\n",
       " ('MLO2', 4),\n",
       " ('functional categories', 4),\n",
       " ('IL 33', 4),\n",
       " ('Ce', 4),\n",
       " ('genome wide association studies', 4),\n",
       " ('P53', 4),\n",
       " ('CT', 4),\n",
       " ('DNMT3A', 4),\n",
       " ('Obesity', 4),\n",
       " ('HGPS', 4),\n",
       " ('DNA extraction', 4),\n",
       " ('N terminal', 4),\n",
       " ('EDL muscle', 4),\n",
       " ('soleus', 4),\n",
       " ('World War II', 4),\n",
       " ('MPs', 4),\n",
       " ('T1DM', 4),\n",
       " ('developing countries', 4),\n",
       " ('vitamin K1', 4),\n",
       " ('Middle East', 4),\n",
       " ('FR', 4),\n",
       " ('phyA', 4),\n",
       " ('HIV status', 4),\n",
       " ('9th Congress', 4),\n",
       " ('ssDNA', 4),\n",
       " ('2008 Summer Olympics', 4),\n",
       " ('TLR9', 4),\n",
       " ('feature selection', 4),\n",
       " ('ESCC', 4),\n",
       " ('pre ', 4),\n",
       " ('pathologist', 4),\n",
       " ('genetic factors', 4),\n",
       " ('computational analysis', 4),\n",
       " ('SARS Cov 2', 4),\n",
       " ('PA', 4),\n",
       " ('Infertility', 4),\n",
       " ('adverse effects', 4),\n",
       " ('2014', 4),\n",
       " ('Bosnia and Herzegovina', 4),\n",
       " ('Cas', 4),\n",
       " ('treatment group', 4),\n",
       " ('right', 4),\n",
       " ('MSCs', 4),\n",
       " ('Ethiopia', 4),\n",
       " ('AUC', 4),\n",
       " ('Molecule', 4),\n",
       " ('AFP', 4),\n",
       " ('BCI loop', 4),\n",
       " ('monolog', 4),\n",
       " ('gastrointestinal dysfunction', 4),\n",
       " ('expression profiles', 4),\n",
       " ('Qinghai', 4),\n",
       " ('Andean', 4),\n",
       " ('16S rRNA', 4),\n",
       " ('NRPS', 4),\n",
       " ('CK7', 4),\n",
       " ('CK20', 4),\n",
       " ('CKL', 4),\n",
       " ('YAP', 4),\n",
       " ('J. J. Smith', 4),\n",
       " ('edible part', 4),\n",
       " ('essential HM', 4),\n",
       " ('motile genera', 4),\n",
       " ('pro inflammatory genes', 4),\n",
       " ('multiplex metabolite', 4),\n",
       " ('qPCR', 4),\n",
       " ('School of Medicine', 4),\n",
       " ('transmembrane helix', 4),\n",
       " ('Plasmodium', 4),\n",
       " ('health status', 4),\n",
       " ('reaction mechanism', 4),\n",
       " ('halteres', 4),\n",
       " ('Locator®', 4),\n",
       " ('blue patrice', 4),\n",
       " ('Lepidoptera', 4),\n",
       " ('CGI58 deficient mouse placenta', 4),\n",
       " ('LV.org', 4),\n",
       " ('GO', 4),\n",
       " ('area under the curve', 4),\n",
       " ('BRCA2', 4),\n",
       " ('VITAL DEP', 4),\n",
       " ('linear regression', 4),\n",
       " ('prostate weight', 4),\n",
       " ('ABO gene', 4),\n",
       " ('online software', 4),\n",
       " ('gnomAD', 4),\n",
       " ('PS', 4),\n",
       " ('Sap2', 4),\n",
       " ('NDUFA4', 4),\n",
       " ('E. coli', 4),\n",
       " ('Short FES I', 4),\n",
       " ('HP axis', 4),\n",
       " ('Mice', 4),\n",
       " ('H1N1pdm', 4),\n",
       " ('29.7', 4),\n",
       " ('Se.', 4),\n",
       " ('XRD', 4),\n",
       " ('EGFR inhibitor', 4),\n",
       " ('Poland', 4),\n",
       " ('vitamin supplement', 4),\n",
       " ('12R LOX', 4),\n",
       " ('Australia', 4),\n",
       " ('FG motif', 4),\n",
       " ('homotypic', 4),\n",
       " ('evisceration', 4),\n",
       " ('Ningxia', 4),\n",
       " ('Inner Mongolia', 4),\n",
       " (\"Alzheimer's\", 4),\n",
       " ('CRPC', 4),\n",
       " ('Pholidota', 4),\n",
       " ('short chain fatty acid', 4),\n",
       " ('NPP 1/Nup54', 4),\n",
       " ('NPP 6/Nup160', 4),\n",
       " ('NPP 7/Nup153', 4),\n",
       " ('Pregnancy', 4),\n",
       " ('pretreatment', 4),\n",
       " ('DNT positive compound', 4),\n",
       " ('PRAME', 4),\n",
       " ('IRG1 deficiency', 4),\n",
       " ('AlphaFold', 4),\n",
       " ('Azores', 4),\n",
       " ('Cabo Verde', 4),\n",
       " ('atomic force microscopy', 4),\n",
       " ('corpus', 4),\n",
       " ('metformin', 4),\n",
       " ('MPO', 4),\n",
       " ('docetaxel', 4),\n",
       " ('MT', 4),\n",
       " ('CD8+ T cells', 4),\n",
       " ('mutagen', 4),\n",
       " ('CXCL8', 4),\n",
       " ('LASV', 4),\n",
       " ('HR proficient', 4),\n",
       " ('BR signaling', 4),\n",
       " ('microcephaly', 4),\n",
       " ('Guillain Barré syndrome', 4),\n",
       " ('Cancer Genome Atlas', 4),\n",
       " ('Enterobacteriaceae', 4),\n",
       " ('HMBOX1', 4),\n",
       " ('circRNA', 4),\n",
       " ('Statistical analysis', 4),\n",
       " ('Gene Ontology', 4),\n",
       " ('publication date', 4),\n",
       " ('FAIR Cookbook', 4),\n",
       " ('protein protein interaction network', 4),\n",
       " ('Cytoscape', 4),\n",
       " ('nDart1 0', 4),\n",
       " ('GPCR', 4),\n",
       " ('SHH', 4),\n",
       " ('deubiquitinase', 4),\n",
       " ('DC3s', 4),\n",
       " ('coatis', 4),\n",
       " ('Fusarium wilt of banana', 4),\n",
       " ('protease core 2 domain', 4),\n",
       " ('ROS', 4),\n",
       " ('Proteomic', 4),\n",
       " ('two dose vaccination', 4),\n",
       " ('hyperbaric chamber', 4),\n",
       " ('dinotefuran', 4),\n",
       " ('categorized', 4),\n",
       " ('heterodimer', 4),\n",
       " ('yield', 4),\n",
       " ('social determinants of health', 4),\n",
       " ('Olanzapine', 4),\n",
       " ('NM', 4),\n",
       " ('trimer', 4),\n",
       " ('TSP superfamily', 4),\n",
       " ('tubulointerstitial fibrotic area', 4),\n",
       " ('before', 4),\n",
       " ('ALT', 4),\n",
       " ('biochemical blood factors', 4),\n",
       " ('TAA', 4),\n",
       " ('combined testing strategies', 4),\n",
       " ('neuroepithelial tumour', 4),\n",
       " ('ATR', 4),\n",
       " ('RPA32', 4),\n",
       " ('reverse phase', 4),\n",
       " ('condensin', 4),\n",
       " ('Gram negative', 4),\n",
       " ('Gram positive', 4),\n",
       " ('Lett.', 4),\n",
       " ('heat activated TRP channel', 4),\n",
       " ('Fas CD40', 4),\n",
       " ('Alpha diversity indices', 4),\n",
       " ('Hormozgan province', 4),\n",
       " ('Human Genome Project', 4),\n",
       " ('protein ligand complex', 4),\n",
       " ('up regulated', 4),\n",
       " ('spinal onset ALS', 4),\n",
       " ('Guangdong', 4),\n",
       " ('worldwide pandemic like the one that we are experiencing now since 2019',\n",
       "  4),\n",
       " ('pore domain', 4),\n",
       " ('TRPV2', 4),\n",
       " ('adjuvants', 4),\n",
       " ('S protein', 4),\n",
       " ('nasal turbinates', 4),\n",
       " ('soft palate', 4),\n",
       " ('Severe acute respiratory syndrome coronavirus 2', 4),\n",
       " ('single nucleotide polymorphism', 4),\n",
       " ('hepatitis B', 4),\n",
       " ('GEO database', 4),\n",
       " ('BMP SMAD pathway', 4),\n",
       " ('CFP', 4),\n",
       " ('positive feedback loop', 4),\n",
       " ('negative feedback loop', 4),\n",
       " ('stochastic integral', 4),\n",
       " ('TT', 4),\n",
       " ('Iberian Peninsula', 4),\n",
       " ('rRNA', 4),\n",
       " ('PA conflict determinants in Lesser Poland', 4),\n",
       " ('IL 4', 4),\n",
       " ('tonsil', 4),\n",
       " ('tonsillitis', 4),\n",
       " ('Genome wide association studies', 4),\n",
       " ('NO', 4),\n",
       " ('Myxozoa', 4),\n",
       " ('hereditary breast and ovarian cancer risk', 4),\n",
       " ('ABRAXAS1', 4),\n",
       " ('JAK1', 4),\n",
       " ('ARDS', 4),\n",
       " ('ceramide', 4),\n",
       " ('histological subtypes', 4),\n",
       " ('renal function', 4),\n",
       " ('Actinobacteria', 4),\n",
       " ('viral replication cycle', 4),\n",
       " ('GhHSP70 26', 4),\n",
       " ('CKD bone', 4),\n",
       " ('Con bone', 4),\n",
       " ('amoxicillin', 4),\n",
       " ('low SDI', 4),\n",
       " ('A.F.N.', 4),\n",
       " ('delivery system', 4),\n",
       " ('Holzer et al.', 4),\n",
       " ('New York City', 4),\n",
       " ('Viral sequences', 4),\n",
       " ('Nitrospira', 4),\n",
       " ('Maranhão', 4),\n",
       " ('FeLV', 4),\n",
       " ('Carbapenem', 4),\n",
       " ('ATG9', 4),\n",
       " ('ONC201', 4),\n",
       " ('response speed', 4),\n",
       " ('raspberry  MS medium', 4),\n",
       " ('human SEs', 4),\n",
       " ('DENV 2', 4),\n",
       " ('Hofmeister effect', 4),\n",
       " ('FA', 4),\n",
       " ('Phototherapy', 4),\n",
       " ('P2', 4),\n",
       " ('P3', 4),\n",
       " ('adult stage', 4),\n",
       " ('Korean provinces', 4),\n",
       " ('CRNDE', 4),\n",
       " ('CINC 2', 4),\n",
       " ('Cas13', 4),\n",
       " ('TPST2', 4),\n",
       " ('multiple pattern recognition receptor', 4),\n",
       " ('CD44', 4),\n",
       " ('CRE', 4),\n",
       " ('S F', 4),\n",
       " ('S D', 4),\n",
       " ('poorly understood', 4),\n",
       " ('BC progression', 4),\n",
       " ('CCN4 6', 4),\n",
       " ('interstitial shear stress', 4),\n",
       " ('GSH', 4),\n",
       " ('White population', 4),\n",
       " ('MED', 4),\n",
       " ('MEAM1', 4),\n",
       " ('Agavoideae', 4),\n",
       " ('DMSO', 4),\n",
       " ('CVOs', 4),\n",
       " ('H', 4),\n",
       " ('Zika infection during pregnancy', 4),\n",
       " ('Peroxisome biogenesis factor', 4),\n",
       " ('ACE2', 4),\n",
       " ('rectal cancer not associated with prostate cancer', 4),\n",
       " ('fusion protein', 4),\n",
       " ('CHAF1A', 4),\n",
       " ('vitamin B deficiency', 4),\n",
       " ('Atherosclerosis', 4),\n",
       " ('50 mM glucose', 4),\n",
       " ('IDD', 4),\n",
       " ('ACPA', 4),\n",
       " ('Centrifuge', 4),\n",
       " ('Amazonas River', 4),\n",
       " ('Tr.', 4),\n",
       " ('W chromosome', 4),\n",
       " ('Checkpoint blockade immunotherapy', 4),\n",
       " ('Others', 4),\n",
       " ('Saxony Anhalt', 4),\n",
       " ('SPOCK2', 4),\n",
       " ('miR 210', 4),\n",
       " ('repressors', 4),\n",
       " ('IRF3', 4),\n",
       " ('Synergy', 4),\n",
       " ('clinical presentation', 4),\n",
       " ('Values domain', 4),\n",
       " ('O group', 4),\n",
       " ('HI', 4),\n",
       " ('KO mice', 4),\n",
       " ('infarcted heart', 4),\n",
       " ('GW', 4),\n",
       " ('D', 4),\n",
       " ('mesophilic enzymes', 4),\n",
       " ('London', 4),\n",
       " ('follow up', 4),\n",
       " ('Dagongba Glacier', 4),\n",
       " ('Morus laevigata Wall', 4),\n",
       " ('G protein', 4),\n",
       " ('Ex + PR', 4),\n",
       " ('S6K1', 4),\n",
       " ('SJs', 4),\n",
       " ('ECs', 4),\n",
       " ('N:P ratio', 4),\n",
       " ('HF', 4),\n",
       " ('IL 1', 4),\n",
       " ('OTUs', 4),\n",
       " ('1 2 days', 4),\n",
       " ('Hippo pathway', 4),\n",
       " ('MUS81', 4),\n",
       " ('IgG2b', 4),\n",
       " ('PLWH', 4),\n",
       " ('high dose EID CT', 4),\n",
       " ('Interrater agreement', 4),\n",
       " ('PCD CT', 4),\n",
       " ('OSF9 ADCFM', 4),\n",
       " ('ComC', 4),\n",
       " ('orthologs', 4),\n",
       " ('LT', 4),\n",
       " ('histomorphometric', 4),\n",
       " ('working memory', 4),\n",
       " ('FTLD TDP', 4),\n",
       " ('acute myocardial infarction', 4),\n",
       " ('AMI', 4),\n",
       " ('P. Auruginosa', 4),\n",
       " ('muscle group', 4),\n",
       " ('MPN BP', 4),\n",
       " ('KEGG pathway', 4),\n",
       " ('Psiocene', 4),\n",
       " ('BDNF', 4),\n",
       " ('Eucalyptus globulus leaf oil', 4),\n",
       " ('Mivebresib', 4),\n",
       " ('proinflammatory mediators', 4),\n",
       " ('cerebral infarction', 4),\n",
       " ('SGLT2i', 4),\n",
       " ('white bellied pangolin', 4),\n",
       " ('MPS I', 4),\n",
       " ('Wumei Bolus', 4),\n",
       " ('PPI network construction', 4),\n",
       " ('BALB/c', 4),\n",
       " ('Hub DERBGs', 4),\n",
       " ('GII', 4),\n",
       " ('LUADs', 4),\n",
       " ('salvage/recycling pathway', 4),\n",
       " ('miR 200a', 4),\n",
       " ('intercropping system', 4),\n",
       " ('legal trade', 4),\n",
       " ('20S, 24S MR2', 4),\n",
       " ('group J', 4),\n",
       " ('NAG', 4),\n",
       " ('OTA', 4),\n",
       " ('bi layer', 4),\n",
       " ('top layer', 4),\n",
       " ('bottom layer', 4),\n",
       " ('root system', 4),\n",
       " ('Piauí', 4),\n",
       " ('TN', 4),\n",
       " ('FEN', 4),\n",
       " ('REM', 4),\n",
       " ('MOR', 4),\n",
       " ('22q11.2 deletion syndrome', 4),\n",
       " ('contrast media', 4),\n",
       " ('CI AKI', 4),\n",
       " ('Hamilton Rating Scale for Anxiety', 4),\n",
       " ('IL 27', 4),\n",
       " ('R Ras KO', 4),\n",
       " ('Physical activity', 4),\n",
       " ('myotube', 4),\n",
       " ('diabet', 4),\n",
       " ('HCR', 4),\n",
       " ('widefield', 4),\n",
       " ('RHEX', 4),\n",
       " ('MCs', 4),\n",
       " ('Akt', 4),\n",
       " ('caput', 4),\n",
       " ('cauda', 4),\n",
       " ('Ceará', 4),\n",
       " ('internode', 4),\n",
       " ('selective attention', 4),\n",
       " ('DUT 3 isoform', 4),\n",
       " ('growth related processes', 4),\n",
       " ('Mixed bone marrow chimera', 4),\n",
       " ('osteogenic differentiation', 3),\n",
       " ('RBM20', 3),\n",
       " ('DNA binding', 3),\n",
       " ('RNAs', 3),\n",
       " ('Arabidopsis thaliana', 3),\n",
       " ('TLR4', 3),\n",
       " ('Malaria', 3),\n",
       " ('high risk of bias', 3),\n",
       " ('La evidencia es de certeza baja a muy baja', 3),\n",
       " ('Los retenedores removibles tuvieron más probabilidades de causar molestias',\n",
       "  3),\n",
       " ('caries', 3),\n",
       " ('Igfbp 3', 3),\n",
       " ('cyclin dependent kinase', 3),\n",
       " ('cryo EM', 3),\n",
       " ('IDPs', 3),\n",
       " ('hierarchy', 3),\n",
       " ('histone H3', 3),\n",
       " ('Vaccine preventable diseases', 3),\n",
       " ('preclinical studies', 3),\n",
       " ('cell state', 3),\n",
       " ('biological function', 3),\n",
       " ('RNAi', 3),\n",
       " ('frailty model', 3),\n",
       " ('copula', 3),\n",
       " ('viremia', 3),\n",
       " ('S2', 3),\n",
       " ('MPCs', 3),\n",
       " ('non alcoholic fatty liver disease', 3),\n",
       " ('UNESCO', 3),\n",
       " ('John F. Kennedy School of Government', 3),\n",
       " ('Harvard University', 3),\n",
       " ('Drosophila melanogaster', 3),\n",
       " ('self ', 3),\n",
       " ('study partner', 3),\n",
       " ('CD16a', 3),\n",
       " ('matrix protein', 3),\n",
       " ('Rawalpindi', 3),\n",
       " ('E coli', 3),\n",
       " ('saponin', 3),\n",
       " ('tetraspanin', 3),\n",
       " ('T DM1', 3),\n",
       " ('Chongming', 3),\n",
       " ('chi square test', 3),\n",
       " ('statistically significant', 3),\n",
       " ('FTIR', 3),\n",
       " ('AgNPs', 3),\n",
       " ('pseudogene', 3),\n",
       " ('spatial component', 3),\n",
       " ('Tolvaptan', 3),\n",
       " ('ADPKD', 3),\n",
       " ('DeepSeqProt', 3),\n",
       " ('transcriptional program', 3),\n",
       " ('vitamin B6', 3),\n",
       " ('knowledge gap', 3),\n",
       " ('Sm', 3),\n",
       " ('GJB2', 3),\n",
       " ('ES', 3),\n",
       " ('physical activity levels', 3),\n",
       " ('PCa', 3),\n",
       " ('Hutchinson Gilford Progeria Syndrome', 3),\n",
       " ('DNMT1', 3),\n",
       " ('wetting', 3),\n",
       " ('OA', 3),\n",
       " ('clinical application', 3),\n",
       " ('transporters', 3),\n",
       " ('chemoattractant', 3),\n",
       " ('Symbiodiniaceae', 3),\n",
       " ('epitope', 3),\n",
       " ('B ALL', 3),\n",
       " ('IL 15', 3),\n",
       " ('Fersi', 3),\n",
       " ('Halavi', 3),\n",
       " ('keystone families', 3),\n",
       " ('MFS', 3),\n",
       " ('ex vivo', 3),\n",
       " ('TamR', 3),\n",
       " ...]"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "generator.word_counter.most_common()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "f76e8a0d",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_opp = generator.get_df_with_relation('instance of')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "9f398ed1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>head</th>\n",
       "      <th>type</th>\n",
       "      <th>tail</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>COVID pandemic</td>\n",
       "      <td>has cause</td>\n",
       "      <td>SARS CoV 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has effect</td>\n",
       "      <td>COVID pandemic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has part</td>\n",
       "      <td>Alpha</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has part</td>\n",
       "      <td>Delta</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has part</td>\n",
       "      <td>Omicron</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has effect</td>\n",
       "      <td>ongoing pandemic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>ongoing pandemic</td>\n",
       "      <td>has cause</td>\n",
       "      <td>SARS CoV 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>MIS C</td>\n",
       "      <td>has effect</td>\n",
       "      <td>SARS CoV 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has effect</td>\n",
       "      <td>MIS C</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>MIS C</td>\n",
       "      <td>has cause</td>\n",
       "      <td>SARS CoV 2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>89 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                head        type              tail\n",
       "0     COVID pandemic   has cause        SARS CoV 2\n",
       "1         SARS CoV 2  has effect    COVID pandemic\n",
       "2         SARS CoV 2    has part             Alpha\n",
       "3         SARS CoV 2    has part             Delta\n",
       "4         SARS CoV 2    has part           Omicron\n",
       "..               ...         ...               ...\n",
       "84        SARS CoV 2  has effect  ongoing pandemic\n",
       "85  ongoing pandemic   has cause        SARS CoV 2\n",
       "86             MIS C  has effect        SARS CoV 2\n",
       "87        SARS CoV 2  has effect             MIS C\n",
       "88             MIS C   has cause        SARS CoV 2\n",
       "\n",
       "[89 rows x 3 columns]"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "generator.get_df_with_word('SARS CoV 2')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "bcad373d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<bound method Counter.most_common of Counter({'subclass of': 2741, 'part of': 1384, 'has part': 1348, 'instance of': 1052, 'opposite of': 676, 'different from': 554, 'has effect': 542, 'has cause': 515, 'facet of': 488, 'subject has role': 310, 'parent taxon': 281, 'use': 264, 'country': 235, 'medical condition treated': 214, 'drug used for treatment': 191, 'followed by': 141, 'studied by': 132, 'uses': 128, 'studies': 117, 'follows': 110, 'contains administrative territorial entity': 67, 'located in the administrative territorial entity': 63, 'connects with': 60, 'shares border with': 55, 'said to be the same as': 53, 'point in time': 50, 'product or material produced': 47, 'encodes': 45, 'taxonomic type': 45, 'used by': 36, 'parent organization': 26, 'subsidiary': 25, 'developer': 24, 'main subject': 23, 'continent': 21, 'field of work': 18, 'country of origin': 15, 'author': 14, 'programming language': 14, 'number of participants': 13, 'capital': 13, 'location': 11, 'diplomatic relation': 11, 'publication date': 10, 'located on terrain feature': 10, 'based on': 9, 'is a list of': 8, 'manufacturer': 8, 'endemic to': 7, 'inception': 7, 'publisher': 7, 'discoverer or inventor': 7, 'affiliation': 7, 'length': 6, 'mouth of the watercourse': 6, 'named after': 5, 'Gram staining': 5, 'tributary': 5, 'notable work': 4, 'spouse': 4, 'significant event': 4, 'operator': 4, 'conferred by': 3, 'has parts of the class': 3, 'language of work or name': 3, 'member of': 3, 'end time': 3, 'award received': 3, 'mountain range': 3, 'field of this occupation': 3, 'applies to jurisdiction': 3, 'participant': 3, 'located in or next to body of water': 3, 'ethnic group': 3, 'owned by': 2, 'published in': 2, 'practiced by': 2, 'sibling': 2, 'replaces': 2, 'replaced by': 2, 'basin country': 2, 'capital of': 2, 'creator': 2, 'twinned administrative body': 2, 'start time': 2, 'participant in': 2, 'founded by': 2, 'influenced by': 1, 'headquarters location': 1, 'winner': 1, 'part of the series': 1, 'father': 1, 'child': 1, 'occupation': 1, 'depicts': 1, 'part': 1, 'location of formation': 1, 'subclass of <triplet>PLEKHM3': 1, 'maintained by': 1, 'operating area': 1, 'language used': 1, 'heritage designation': 1, 'ranking': 1, 'work location': 1, 'number of episodes': 1, 'event distance': 1, 'derivative work': 1, 'work period (start)': 1})>"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "generator.relations_counter.most_common"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "affcce32",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cd5a0467",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "ea0a77e4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>head</th>\n",
       "      <th>type</th>\n",
       "      <th>tail</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>arginine serine rich</td>\n",
       "      <td>instance of</td>\n",
       "      <td>domain</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Metabolic scaling</td>\n",
       "      <td>instance of</td>\n",
       "      <td>inverse correlation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>WRAB18</td>\n",
       "      <td>instance of</td>\n",
       "      <td>promoter sequence</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>cociente de riesgos instantáneos</td>\n",
       "      <td>instance of</td>\n",
       "      <td>intervalos de confianza</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Little's Irregularity Index</td>\n",
       "      <td>instance of</td>\n",
       "      <td>notificación</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1047</th>\n",
       "      <td>glutathione peroxidase 1</td>\n",
       "      <td>instance of</td>\n",
       "      <td>oxidative stress markers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1048</th>\n",
       "      <td>individual milk urea concentration</td>\n",
       "      <td>instance of</td>\n",
       "      <td>indicator trait</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1049</th>\n",
       "      <td>Dynamic protein phosphorylation and dephosphor...</td>\n",
       "      <td>instance of</td>\n",
       "      <td>regulatory mechanisms</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1050</th>\n",
       "      <td>Pleistocene</td>\n",
       "      <td>instance of</td>\n",
       "      <td>climate oscillations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1051</th>\n",
       "      <td>DNMTis</td>\n",
       "      <td>instance of</td>\n",
       "      <td>combination therapy</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1052 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   head         type  \\\n",
       "0                                  arginine serine rich  instance of   \n",
       "1                                     Metabolic scaling  instance of   \n",
       "2                                                WRAB18  instance of   \n",
       "3                      cociente de riesgos instantáneos  instance of   \n",
       "4                           Little's Irregularity Index  instance of   \n",
       "...                                                 ...          ...   \n",
       "1047                           glutathione peroxidase 1  instance of   \n",
       "1048                 individual milk urea concentration  instance of   \n",
       "1049  Dynamic protein phosphorylation and dephosphor...  instance of   \n",
       "1050                                        Pleistocene  instance of   \n",
       "1051                                             DNMTis  instance of   \n",
       "\n",
       "                          tail  \n",
       "0                       domain  \n",
       "1          inverse correlation  \n",
       "2            promoter sequence  \n",
       "3      intervalos de confianza  \n",
       "4                 notificación  \n",
       "...                        ...  \n",
       "1047  oxidative stress markers  \n",
       "1048           indicator trait  \n",
       "1049     regulatory mechanisms  \n",
       "1050      climate oscillations  \n",
       "1051       combination therapy  \n",
       "\n",
       "[1052 rows x 3 columns]"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_opp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "9dd56407",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "G = nx.from_pandas_edgelist(df_opp,'head', 'tail')\n",
    "pos = nx.spring_layout(G)\n",
    "nx.draw(G,node_size= 40, with_labels=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "cad12da3",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_opp = generator.get_df_with_word_relation(relations=['has cause'],words=['SARS CoV 2'])\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "b123289b",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_opp.to_csv(\"data/encodesproteion.csv\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "74e8f978",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>head</th>\n",
       "      <th>type</th>\n",
       "      <th>tail</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>COVID pandemic</td>\n",
       "      <td>has cause</td>\n",
       "      <td>SARS CoV 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has effect</td>\n",
       "      <td>COVID pandemic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has part</td>\n",
       "      <td>Alpha</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has part</td>\n",
       "      <td>Delta</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has part</td>\n",
       "      <td>Omicron</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has effect</td>\n",
       "      <td>ongoing pandemic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>ongoing pandemic</td>\n",
       "      <td>has cause</td>\n",
       "      <td>SARS CoV 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>MIS C</td>\n",
       "      <td>has effect</td>\n",
       "      <td>SARS CoV 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>SARS CoV 2</td>\n",
       "      <td>has effect</td>\n",
       "      <td>MIS C</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>MIS C</td>\n",
       "      <td>has cause</td>\n",
       "      <td>SARS CoV 2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>89 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                head        type              tail\n",
       "0     COVID pandemic   has cause        SARS CoV 2\n",
       "1         SARS CoV 2  has effect    COVID pandemic\n",
       "2         SARS CoV 2    has part             Alpha\n",
       "3         SARS CoV 2    has part             Delta\n",
       "4         SARS CoV 2    has part           Omicron\n",
       "..               ...         ...               ...\n",
       "84        SARS CoV 2  has effect  ongoing pandemic\n",
       "85  ongoing pandemic   has cause        SARS CoV 2\n",
       "86             MIS C  has effect        SARS CoV 2\n",
       "87        SARS CoV 2  has effect             MIS C\n",
       "88             MIS C   has cause        SARS CoV 2\n",
       "\n",
       "[89 rows x 3 columns]"
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "generator.get_df_with_word('SARS CoV 2')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0e5cbdc0",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6f649438",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
